September 14, 2021 Comments Off on New patent for Genentech Inc drug ROZLYTREK Posted in: Patent Added Annual Drug Patent Expirations for ROZLYTREK Rozlytrek is a drug marketed by Genentech Inc and is included in one NDA. It is available from one supplier. There are twelve patents…
The post New patent for Genentech Inc drug ROZLYTREK appeared first on D…
September 14, 2021 Comments Off on New patent for Acerus drug NATESTO Posted in: Patent Added Annual Drug Patent Expirations for NATESTO Natesto is a drug marketed by Acerus and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent for Acerus drug NATESTO appeared first on DrugPatentWa…
